Patents Examined by Glennon N. Hollrah
  • Patent number: 5086074
    Abstract: Compounds of the formula ##STR1## and pharmaceutically acceptable salt thereof, wherein R.sup.2 is selected from hydroxy and lower alkoxy, R.sup.5 is lower alkyl, and R.sup.11 and R.sup.12 are independently selected from hydrogen, halo, hydroxy, methoxy, and lower alkyl, are selective .alpha..sub.2 adrenergic receptor antagonists useful in the treatment of glaucoma.
    Type: Grant
    Filed: March 26, 1990
    Date of Patent: February 4, 1992
    Assignee: Abbott Laboratories
    Inventors: John F. DeBernardis, Robert E. Zelle, Fatima Z. Basha
  • Patent number: 4659817
    Abstract: Compounds and methods featuring, in one aspect, compositions containing an organic boronic acid and one or more reporter groups.
    Type: Grant
    Filed: August 8, 1984
    Date of Patent: April 21, 1987
    Assignee: The Children's Medical Center Corporation
    Inventors: Paul M. Gallop, Mercedes Paz
  • Patent number: 4578477
    Abstract: This disclosure relates to N-substituted benzothiazolines and N-substituted benzoxazolines which are useful as plant growth regulants. This disclosure further relates to plant growth regulant compositions containing such N-substituted benzothiazolines and N-substituted benzoxazolines and to methods of regulating the growth of leguminous plants employing such compounds and compositions.
    Type: Grant
    Filed: December 31, 1979
    Date of Patent: March 25, 1986
    Assignee: Monsanto Company
    Inventor: John J. D'Amico